TAK-660-403 app for iPhone and iPad

4.2 ( 5632 ratings )

Medical
Developer: ERT,INC

Free

Current version: 1.2, last update: 3 months ago
First release : 24 Feb 2020
App size: 38.15 Mb

An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)